Skip to main content

Table 2 Prevalence of the most common disorders at a fine-level of diagnostic precision recorded in Boxers (n = 3,219) under primary veterinary care at UK practices participating in the VetCompass™ Programme from January 1st, 2016 to December 31st, 2016. Disorders with 40 or more events included

From: Demography, common disorders and mortality of Boxer dogs under primary veterinary care in the UK

Fine-level Disorder

No

Overall prevalence %

95% CIa

Median age (years)

Female prevalence %

Male prevalence %

Sex P-value*

White prevalence

Non-white prevalence

Colour P-value**

Otitis externa

230

7.15

6.31–8.09

5.50

7.00

7.27

0.772

7.30

7.35

0.974

Epulis

188

5.84

5.08–6.70

8.75

6.36

5.35

0.223

5.71

5.83

0.935

Corneal ulceration

161

5.00

4.30–5.81

8.77

4.60

5.35

0.336

6.03

5.14

0.503

Periodontal disease

149

4.63

3.96–5.41

8.66

5.58

3.72

0.012

6.98

4.53

0.054

Heart murmur

138

4.29

3.64–5.04

7.55

3.50

4.98

0.038

4.13

4.38

0.835

Skin mass

138

4.29

3.64–5.04

8.70

5.32

3.36

0.006

4.76

4.38

0.756

Obesity

123

3.82

3.21–4.54

6.64

4.09

3.54

0.423

3.17

3.81

0.575

Overgrown nail(s)

118

3.67

3.07–4.37

6.77

4.02

3.24

0.239

3.17

3.81

0.575

Hypersensitivity allergy disorder

95

2.95

2.42–3.59

4.71

3.11

2.82

0.628

2.86

3.09

0.824

Aggression

90

2.80

2.28–3.42

5.96

1.56

3.96

 < 0.001

2.54

2.93

0.694

Diarrhoea

85

2.64

2.14–3.25

2.87

2.33

2.94

0.284

2.86

2.67

0.843

Osteoarthritis

82

2.55

2.06–3.15

9.97

2.66

2.46

0.725

3.49

2.55

0.327

Post-operative complication

68

2.11

1.67–2.67

3.61

1.88

2.28

0.427

1.27

2.21

0.273

Urinary incontinence

65

2.02

1.59–2.57

9.91

3.70

0.48

 < 0.001

1.90

2.02

0.891

Aural discharge

64

1.99

1.56–2.53

4.14

1.49

2.46

0.049

2.54

2.06

0.573

Claw injury

63

1.96

1.53–2.50

4.82

1.95

1.92

0.961

1.27

1.98

0.380

Mast cell tumour

60

1.86

1.45–2.39

7.24

2.01

1.74

0.575

2.54

1.90

0.444

Alopecia

59

1.83

1.42–2.36

6.21

2.14

1.56

0.223

1.90

1.87

0.962

Pyoderma

59

1.83

1.42–2.36

5.27

1.75

1.92

0.719

2.86

1.79

0.191

Lameness

57

1.77

1.37–2.29

5.87

1.56

1.98

0.362

2.54

1.71

0.298

Hypothyroidism

54

1.68

1.29–2.18

8.84

1.56

1.80

0.589

0.63

1.83

0.122

Thin

53

1.65

1.26–2.15

2.70

1.62

1.68

0.893

2.86

1.52

0.081

Conjunctivitis

52

1.62

1.23–2.11

4.98

1.56

1.68

0.779

2.22

1.60

0.415

Skin disorder

50

1.55

1.18–2.04

5.47

1.75

1.38

0.399

1.59

1.64

0.946

Limb mass

49

1.52

1.15–2.01

8.14

1.49

1.56

0.872

1.27

1.64

0.622

Death—unknown cause

47

1.46

1.10–1.94

10.75

1.49

1.38

0.793

2.54

1.26

0.067

Infectious canine tracheobronchitis

47

1.46

1.10–1.94

4.35

1.17

1.74

0.176

0.95

1.45

0.479

Seizure disorder

47

1.46

1.10–1.94

9.59

1.43

1.50

0.860

2.22

1.41

0.262

Vomiting

47

1.46

1.10–1.94

4.34

1.49

1.44

0.906

2.22

1.49

0.320

Anal sac impaction

46

1.43

1.07–1.90

5.51

1.10

1.74

0.128

0.95

1.60

0.376

Cruciate disease

43

1.34

0.99–1.79

6.15

0.97

1.68

0.081

0.95

1.41

0.508

Atopic dermatitis

42

1.30

0.97–1.76

5.01

1.49

1.14

0.383

2.22

1.26

0.162

Acrochordon

41

1.27

0.94–1.72

7.42

1.04

1.04

0.303

1.59

1.26

0.624

Stiffness

41

1.27

0.94–1.72

10.40

1.23

1.32

0.822

1.27

1.22

0.938

  1. aCI confidence interval. *The P-value reflects prevalence comparison between females and males. **The P-value reflects prevalence comparison between white and non-white Boxers
Back to article page

Canine Medicine and Genetics

ISSN: 2662-9380